Tocilizumab-induced leucocytoclastic vasculitis in a patient with rheumatoid arthritis

Rheumatology (Oxford). 2014 Aug;53(8):1529-30. doi: 10.1093/rheumatology/keu008. Epub 2014 Mar 7.

Authors

Saori Sakaue¹, Shuji Sumitomo², Kanae Kubo¹, Keishi Fujio¹, Kazuhiko Yamamoto¹

Affiliations

¹ Department of Allergy and Rheumatology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
² Department of Allergy and Rheumatology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan. sumitos-tky@umin.ac.jp.

PMID: 24609062
DOI: 10.1093/rheumatology/keu008

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects*
Antibodies, Monoclonal, Humanized / therapeutic use
Antirheumatic Agents / adverse effects*
Antirheumatic Agents / therapeutic use
Arthritis, Rheumatoid / drug therapy*
Female
Humans
Middle Aged
Vasculitis, Leukocytoclastic, Cutaneous / chemically induced*

Substances

Antibodies, Monoclonal, Humanized
Antirheumatic Agents
tocilizumab